Shine Medical Technologies of Madison is moving ahead with an effort to make a vital medical isotope at a new plant in Janesville.
The isotope, molybdenum-99, is needed for about 20 million procedures annually in the United States alone. “Moly-99” quickly decays into a form, technetium-99, that is useful for medical scans used to detect cancer and assess blood supply to the heart.
The UW–Madison spinoff’s Janesville plant is slated to employ about 150.